Live feed
Filing
SC 13G/A
SC 13G/A0000902664-21-000523·Empery Asset Management, LP
Schedule 13G ownership disclosure
Sonnet BioTherapeutics Holdings, Inc.
Security class unavailable · CUSIP: 83548R105
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,707,107
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-000523
- Form type
- SC 13G/A
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- Jan 26, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership